| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |